BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
토요일, 9월 26

MediciNova Inc

MNOVNASDAQ
Trade with Public
Trade with Public
$2.58
-0.07-2.64%
가까이에: Sep 25, 5:00 PM EST
$2.54
-0.04-1.55%
시간외: 7:42 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

MediciNova Analyst Price Targets

Wall Street analyst price targets and consensus rating for MediciNova (MNOV).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$7Upside to Avg. PT+183.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Sep 17, 2026Roth CapitalBoobalan PachaiyappanInitiateBuy$6
May 4, 2026D. Boral CapitalJason KolbertMaintainedBuy$9
More with Benzinga EdgeGet Access

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Buy ratings for MNOV ($6), IBIO ($7), ROIV ($51), and PAY ($42); FHN rated Market Perform at $25.
Avi Kapoor

PRO
Roth Capital Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $6

Roth Capital analyst Boobalan Pachaiyappan initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $6.
Benzinga Newsdesk

This Qualcomm Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

This Cohu Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts changed outlook for top names like SUNB, SLDP, ZVRA, COHU, and MNOV. See analyst ratings page for more info. Consider buying COHU stock.
Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $10

HC Wainwright & Co. analyst Lander Egaña Gorroño initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $10.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved